Article
Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.
Pharmacotherapy - 1 Aug 2025
Rouby Nihal El, Owusu-Obeng Aniwaa, Preuss Michael, Lee Simon, Shi Mingjian, Lape Michael, Martin Lisa J, Namjou-Khales Bahram, Kottyan Leah C, Van Driest Sara L, Mosley Jonathan D, DelBello Melissa P
Abstract excerpt
OBJECTIVES: Second-generation antipsychotic (SGA) medications are frequently prescribed for mental health conditions; however, they are associated with an increased risk of metabolic syndrome (MetS). We aimed to identify genetic associations of SGA-associated MetS (SGA-MetS) using genome-wide approaches within the UK Biobank. We also set out to evaluate if genetically predicted obesity is associated with an...
Topics
- Humans
- Metabolic Syndrome
- Genome-Wide Association Study
- Antipsychotic Agents
- Female
- Male
- United Kingdom
- Middle Aged
- Biological Specimen Banks
- Cross-Sectional Studies
